The study involved cholesterol drug sites Lipitor, Crestor, Vyotrin, and Zetia, assumes a lifetime value of $1,000 for a new start, and defines brand influence by the lift associated with the visits by source of traffic. This does not take into account the combined effect of multiple exposures.For more on Comscore Pharmaceutical Solutions research, please contact John Mangano.